当前位置:首页 - 行情中心 - 西藏药业(600211) - 财务分析 - 现金流量表

西藏药业

(600211)

  

流通市值:116.52亿  总市值:116.52亿
流通股本:3.22亿   总股本:3.22亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,816,346,866.251,030,420,360.83,137,352,266.462,488,285,507.95
  收到的税费返还33,802.59-1,619,757.681,627,627.9
  收到其他与经营活动有关的现金200,949,889110,568,691.59141,273,779.0187,377,827.94
  经营活动现金流入小计2,017,330,557.841,140,989,052.393,280,245,803.152,577,290,963.79
  购买商品、接受劳务支付的现金140,214,268.379,889,498.51218,574,565.99202,955,243
  支付给职工以及为职工支付的现金80,554,876.7150,868,310.45108,250,964.780,721,467.42
  支付的各项税费224,514,239.03109,426,338.49379,541,632.58306,210,871.98
  支付其他与经营活动有关的现金1,092,890,071.21517,353,922.271,569,127,833.961,274,338,468.49
  经营活动现金流出小计1,538,173,455.25757,538,069.722,275,494,997.231,864,226,050.89
  经营活动产生的现金流量净额479,157,102.59383,450,982.671,004,750,805.92713,064,912.9
二、投资活动产生的现金流量:
  收回投资收到的现金2,809,435,209.061,321,000,0004,370,088,463.93,152,991,516.2
  取得投资收益收到的现金19,999,0845,271,887.9321,965,343.6415,787,481.07
  处置固定资产、无形资产和其他长期资产收回的现金净额4,612.051,363.2344,274.86-
  收到的其他与投资活动有关的现金--162,484,572.9161,633,808.81
  投资活动现金流入小计2,829,438,905.111,326,273,251.134,554,882,655.33,330,412,806.08
  购建固定资产、无形资产和其他长期资产支付的现金6,976,145.123,194,382.2415,957,010.3410,974,808.09
  投资支付的现金3,272,687,979.431,695,858,801.365,128,000,0003,920,000,000
  支付其他与投资活动有关的现金4,086,815.07---
  投资活动现金流出小计3,283,750,939.621,699,053,183.65,143,957,010.343,930,974,808.09
  投资活动产生的现金流量净额-454,312,034.51-372,779,932.47-589,074,355.04-600,562,002.01
三、筹资活动产生的现金流量:
  取得借款收到的现金1,022,521,291.83310,000,000960,044,596.77816,728,712.81
  收到其他与筹资活动有关的现金16,541,114.0217,121,130.2149,752,596.6-
  筹资活动现金流入小计1,039,062,405.85327,121,130.211,009,797,193.37816,728,712.81
  偿还债务支付的现金692,362,514.5250,011,046.56482,043,450.52172,032,142.37
  分配股利、利润或偿付利息支付的现金283,624,280.37887,835.71614,742,807.58606,429,827.43
  其中:子公司支付给少数股东的股利、利润1,023,000-1,212,2001,212,200
  支付其他与筹资活动有关的现金177,717,450.32178,286,147.0735,634,096.33-
  筹资活动现金流出小计1,153,704,245.21229,185,029.341,132,420,354.43778,461,969.8
  筹资活动产生的现金流量净额-114,641,839.3697,936,100.87-122,623,161.0638,266,743.01
四、汇率变动对现金及现金等价物的影响-16,251,799.71-21,090,592.86-22,454,136.39-1,319,965.01
五、现金及现金等价物净增加额-106,048,570.9987,516,558.21270,599,153.43149,449,688.89
  加:期初现金及现金等价物余额1,576,500,319.481,576,500,319.481,305,901,166.051,305,901,166.05
  期末现金及现金等价物余额1,470,451,748.491,664,016,877.691,576,500,319.481,455,350,854.94
补充资料:
  净利润571,128,354.71-916,980,955.72-
  资产减值准备3,717,956.24-4,409,036.31-
  固定资产和投资性房地产折旧34,660,527.39-50,681,742.86-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧34,660,527.39-50,681,742.86-
  无形资产摊销11,062,888.83-28,868,856.29-
  长期待摊费用摊销745,842.65-848,553.86-
  处置固定资产、无形资产和其他长期资产的损失0--108,677.06-
  固定资产报废损失-1,284,894.69-27,349.84-
  公允价值变动损失5,092,343.47--1,661,657.85-
  财务费用23,369,940.25-6,655,899.81-
  投资损失-10,108,006.18--7,872,352.36-
  递延所得税-7,269,460.12-18,866,389.41-
  其中:递延所得税资产减少-6,635,255.08-18,528,417.75-
    递延所得税负债增加-634,205.04-337,971.66-
  存货的减少-13,591,247.95--43,304,388.04-
  经营性应收项目的减少45,706,371.49--195,417,961.86-
  经营性应付项目的增加-190,838,786.22-225,408,307.81-
  其他6,315,988.89-368,751.18-
  现金的期末余额1,470,451,748.49-1,576,500,319.48-
  减:现金的期初余额1,576,500,319.48-1,305,901,166.05-
  现金及现金等价物的净增加额-106,048,570.99-270,599,153.43-
公告日期2026-08-142026-04-292026-03-132025-10-31
审计意见(境内)标准无保留意见
TOP↑